您的位置: 首页 > 农业专利 > 详情页

Producing human CD34+CD7+CD5+CD1a− progenitor T cells and method of treatment
专利权人:
发明人:
Juan Carlos Zuniga-Pflucker,Geneve Awong,Ross La Motte-Mohs
申请号:
US14284533
公开号:
US09533009B2
申请日:
2014.05.22
申请国别(地区):
US
年份:
2017
代理人:
摘要:
Human progenitor T cells that are able to successfully engraft a murine thymus and differentiate into mature human T and NK cells are described. The human progenitor T cells have the phenotype CD34+CD7+CD 1a−CD5− or CD34+CD7+CD1a−CD5+ and are derived from human hematopoietic stem cells, embryonic stem cells and induced pluripotent stem cells by coculture with cells expressing a Notch receptor ligand (OP9-DL1 or OP9-DL4). Such cells are useful in a variety of applications including immune reconstitution, the treatment of immunodeficiencies and as carriers for genes used in gene therapy.
来源网站:
中国工程科技知识中心
来源网址:
http://www.ckcest.cn/home/

意 见 箱

匿名:登录

个人用户登录

找回密码

第三方账号登录

忘记密码

个人用户注册

必须为有效邮箱
6~16位数字与字母组合
6~16位数字与字母组合
请输入正确的手机号码

信息补充